Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Observational Retrospective Study of Therapeutic Approaches and Clinical Outcomes in Real Clinical Practice in Russian Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced/Metastatic Gastric and/or Gastroesophageal Junction (GEJ) Adenocarcinoma

NCT05892926 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05892926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05892926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Observational Retrospective Study of Therapeutic Approaches and Clinical Outcomes in Real Clinical Practice in Russian Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced/Metastatic Gastric and/or Gastroesophageal Junction (GEJ) Adenocarcinoma
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
May 30, 2023
Completion date
July 31, 2024
Enrollment
204 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma